Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safely results from the EORTC 18071 phase III trial Meeting Abstract
| Authors: | Eggerrnont, A. M.; Chiarion-Sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; Lobbe, C.; Ferraresi, V.; Smylie, M.; Weber, J. S.; Maio, M.; Konto, C.; Gurunath, R. K.; de Pril, V.; Suciu, S.; Testori, A. |
| Abstract Title: | Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safely results from the EORTC 18071 phase III trial |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613201966 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.lba9008 |
| Notes: | Meeting Abstract: LBA9008 -- Source: Wos |
